# Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

> **NCT07332221** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 435 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Toripalimab monotherapy

## Key facts

- **NCT ID:** NCT07332221
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2029-10-01
- **Final completion:** 2031-10-01
- **Target enrollment:** 435 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07332221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07332221, "Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07332221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*